Alternus Clean Energy to Participate in Upcoming Investor Conferences and Industry Events
07 mars 2024 10h30 HE
|
Alternus Clean Energy
FORT MILL, S.C., March 07, 2024 (GLOBE NEWSWIRE) -- Alternus Clean Energy (NASDAQ: ALCE) (“Alternus” or the “Company”), a leading utility-scale transatlantic, clean energy independent power producer...
Orion Biotechnology Presenting at the 3rd GPCR-Targeted Drug Discovery Summit in Boston
06 mars 2024 20h30 HE
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, March 06, 2024 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference
06 mars 2024 07h01 HE
|
HOOKIPA Pharma Inc.
NEW YORK and VIENNA, Austria, March 06, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary...
Creating an Innovation Culture
05 mars 2024 12h00 HE
|
Alberta Innovates
Marcus Collins, PhD, will deliver a keynote address at Inventures 2024 in Calgary, May 29-31, 2024
Elev8 New Media Announces Sponsorship of the 36th Annual ROTH Conference in Dana Point, CA
05 mars 2024 09h32 HE
|
Elev8 New Media
Elev8 New Media announces its sponsorship of the 36th Annual ROTH Conference
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024
05 mars 2024 09h00 HE
|
Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals CEO Dr. Anatoly Dritschilo will be participating in the Emerging Growth Conference on Wednesday, March 6, 2024 at 11:25 am ET.
NurExone Presenting Novel Regulatory Pathways for Exosomes Therapies at Global Summit
01 mars 2024 16h04 HE
|
NurExone Biologic Inc
NurExone Presenting Novel Regulatory Pathways for Exosomes Therapies at Global Summit
NMD Pharma announces poster and oral presentations on skeletal muscle targeted ClC-1 therapy at two leading neuromuscular disease conferences
01 mars 2024 14h00 HE
|
NMD Pharma
NMD Pharma announces poster and oral presentations on skeletal muscle targeted ClC-1 therapy at two leading neuromuscular disease conferences ClC-1 is a chloride ion channel specifically expressed...
ARKO Corp. Announces Participation in Raymond James 45th Annual Institutional Investors Conference
29 févr. 2024 16h44 HE
|
ARKO CORP.
ARKO presenting at Raymond James Institutional Investors Conference
CARGO Therapeutics to Participate in the 44th Annual Cowen Healthcare Conference
29 févr. 2024 16h01 HE
|
Cargo Therapeutics, Inc.
CARGO Therapeutics announced that the company will participate in the 44th Annual Cowen Healthcare Conference, taking place March 4-6, 2024, in Boston, MA.